Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Published on by Academic Awards

Dr. Pierre-Jean Pintard | Ophthalmology | Best Industrial Research Award

Medical Director at Abbvie, United Kingdom

👨‍⚕️ Dr. Pierre-Jean Pintard is a multilingual Medical Doctor based in London 🇬🇧, with expertise in Clinical Development, Medical Affairs, HEOR, and Pharmacovigilance. Currently Associate Global Medical Director at AbbVie, he has held key roles at Gilead, Bial, and Mylan. He holds an MD from Barts and The London, an MSc in Health Economics from LSE & LSHTM, and specialty training in Pharmaceutical Medicine. He has published in top journals and presented internationally. Fluent in French 🇫🇷, English 🇬🇧, and Spanish 🇪🇸, he is also a pianist 🎹 and certified sailing instructor ⛵.

Publication Profile

Google Scholar

Professional Experience

Dr. Pierre-Jean Pintard is a seasoned global medical leader with extensive experience across top pharmaceutical companies. Currently serving as Associate Global Medical Director at AbbVie 🌐, he leads clinical strategies and evidence generation for Ozurdex. At Gilead Sciences 🇪🇺, he played a pivotal role in maintaining access to Ambisome and launching Epclusa. Previously at Bial 🇵🇹, he managed global medical affairs for the inflammation portfolio. At Mylan 🇬🇧, he launched biosimilars and provided expert medical insights. Earlier roles at Bristol Myers Squibb and William Harvey Institute honed his skills in health outcomes research and clinical science 🔬📊

🎓 Educational Background

Dr. Pierre-Jean Pintard holds a diverse and interdisciplinary academic background. He completed Pharmaceutical Medicine Specialty Training (2019–2020) at NOVA Medical School/University of Aveiro, gaining expertise in protocol design, data analysis, and clinical monitoring 📊. He earned an MSc in International Health Economics and Policy (2016–2017) from LSE & LSHTM, focusing on pharma economics and cost-effectiveness 💶. His MD in Medicine (2011–2015) from Barts and the London included an elective in Kenya 🇰🇪 and a poster presentation at SCMR Nice. He also holds a BSc in Biomedical Sciences (2008–2011) from Queen Mary University, with emphasis on clinical trials and drug design 💊.

💼 Skills & Personal Interests

Dr. Pierre-Jean Pintard is a multilingual professional, fluent in French 🇫🇷 and English 🇬🇧, with proficiency in Spanish 🇪🇸 (C1), and basic knowledge of Portuguese 🇵🇹 and German 🇩🇪 (A2). His technical skills include MS Word, Excel (with Markov models), STATA, Zinc, Epi-Info, and Spotfire 💻. A passionate musician, he studied piano for 9 years at the Conservatoire of Marseille and earned 3rd prize at the Steinway & Sons championship 🎹. He is also an avid sailor ⛵ with 13 years of experience at Marseille Yachting Club and Docklands Sailing Centre, holding a sailing instructor license.

Research Focus

Dr. Pierre-Jean Pintard’s research spans across psychiatry, ophthalmology, and cardiology, reflecting a multidisciplinary focus. His early work explored mental health stigma among medical students 🧠. He has significantly contributed to ophthalmic research, especially in diabetic macular edema, identifying macular volume as a surrogate marker for visual acuity 👁️📊. In cardiology, he co-authored a study comparing cardiac MRI techniques for assessing left atrial volume, enhancing diagnostic precision ❤️🧲. His expertise lies in biomarker identification, clinical imaging, and evidence synthesis, highlighting a strong foundation in clinical research and health outcomes across multiple therapeutic areas.

Conclusion

Dr. Pierre-Jean Pintard is highly suitable for the Research for Best Industrial Research Award.
His industrially relevant clinical research, cross-functional leadership, international collaboration, and proven ability to drive patient-centric innovations align with the award’s objectives.

Publication Top Notes

📘 Medical students’ attitudes about mental illness – PJ Pintard et al. – 🗓️ 2012 – 📊 Cited by: 3 – 🧠🩺
📘 Anatomic biomarkers in diabetic macular edema: Macular volume as a surrogate for visual acuity – PJ Pintard et al. – 🗓️ 2025 – 📊 Cited by: [Data Pending] – 👁️📈
📘 Cardiac MRI techniques for left atrial volume measurement – PJ Pintard et al. – 🗓️ 2015 – 📊 Cited by: [Not Specified] – ❤️🧲

Linlin Xu | Ophthalmology | Best Researcher Award

Published on by Academic Awards

Dr. Linlin Xu | Ophthalmology | Best Researcher Award

Dr. Linlin Xu, Zibo Central Hospital, China

👩‍⚕️ Dr. Linlin Xu is an accomplished ophthalmologist and Associate Chief Physician at Zibo Central Hospital, holding a Medical Doctorate (MD). She specializes in refractive disorders, pediatric eye diseases, and complex ocular surgeries such as LASIK, SMILE, ICL implantation, and strabismus correction. 🏥 Dr. Xu is an active member of several professional bodies including the Shandong Provincial Medical Association 👁️ and holds a leadership role in ocular surface disease prevention. She has published extensively in SCI-indexed and core medical journals, contributing significantly to ophthalmic research and innovation. 📚 Her expertise bridges clinical excellence and academic advancement. 🧠✨

Publication Profile

Orcid

🔗 Professional Affiliations

Dr. Linlin Xu is actively engaged in numerous prestigious medical associations, reflecting her leadership in the field of ophthalmology. 👁️ She is a member of the Optometry Group within both the Shandong Provincial Medical Association and the Shandong Provincial Physicians Association. 🏥 She also serves on the Multidisciplinary Joint Committee for Ophthalmic Optometry and Myopia Prevention and Control. 📘 Notably, Dr. Xu holds the position of Deputy Director of the Ocular Surface Disease Prevention and Treatment Committee under the Shandong Health Promotion and Education Association. 🌟 Additionally, she is a member of the Ophthalmology Branch of the Zibo Medical Association. 🩺

🔬 Clinical Expertise

Dr. Linlin Xu is a highly skilled ophthalmologist with specialized expertise in diagnosing and managing refractive errors, strabismus, and amblyopia. 👁️ Her clinical proficiency extends to advanced surgical techniques, making her a trusted expert in vision correction. 🔍 She performs state-of-the-art corneal refractive laser surgeries, including LASIK and SMILE, ensuring precision and safety for patients. 💡 Additionally, she excels in intraocular refractive surgeries such as Implantable Collamer Lens (ICL) implantation and complex strabismus corrections. 🛠️ Dr. Xu’s comprehensive approach to ocular health combines diagnostic accuracy with surgical excellence, significantly enhancing patient outcomes. 👩‍⚕️✨

📚 Academic Contributions

Dr. Linlin Xu has made significant academic contributions through her research in ophthalmology, particularly in the areas of refractive surgery and clinical eye care. 🧠 She has authored multiple peer-reviewed papers published in SCI-indexed international journals and core domestic medical publications, advancing evidence-based practices in the field. 📝 Her scholarly work reflects a deep commitment to scientific innovation and clinical excellence. 🔬 Dr. Xu’s ability to integrate research with surgical precision enhances both academic and patient care standards. 👩‍⚕️ Her dedication to advancing ophthalmic knowledge positions her as a respected leader and innovator in vision science. 🌟

🔍 Research Focus

Dr. Linlin Xu’s research primarily focuses on corneal diseases, refractive surgery, and pediatric ophthalmology. 👁️ Her studies explore advanced treatments for keratoconus, corneal ectasia, and congenital cataracts, emphasizing procedures like corneal collagen crosslinking (CXL), photorefractive keratectomy (PRK), and intraocular interventions. 🧪 She has also investigated strabismus and thyroid-associated ophthalmopathy, reflecting a multidisciplinary approach. 🧠 Dr. Xu’s publications in SCI-indexed journals highlight her contributions to surgical innovation and postoperative visual outcomes. 📈 Her work serves to bridge clinical practice with evidence-based advancements in corneal and refractive disorder management, especially among young patients. 👩‍⚕️

Conclusion

Dr. Linlin Xu’s outstanding combination of clinical excellence, surgical innovation, and impactful research makes her a strong and deserving nominee for the Research for Best Researcher Award. Her contributions exemplify the qualities of a researcher who not only advances medical knowledge but also elevates patient outcomes in ophthalmology.

Publication Top Notes

  • “Corneal Collagen Crosslinking Combined with Phototherapeutic Keratectomy and Photorefractive Keratectomy for Corneal Ectasia after LASIK”
    Published: 2018
    Journal: Ophthalmic Research
    Summary: This study explores the efficacy of combining corneal collagen crosslinking with phototherapeutic and photorefractive keratectomy to treat corneal ectasia post-LASIK.

  • “Clinical Study of Mitomycin C in Reducing Haze Formation After Ultraviolet A/Riboflavin Crosslinking for Keratoconus”
    Published: 2018
    Journal: Eye & Contact Lens: Science & Clinical Practice
    Summary: This research investigates the role of Mitomycin C in minimizing corneal haze following UV-A/riboflavin crosslinking in keratoconus patients.

  • “Postoperative Visual Function Observation in Congenital Cataract Surgery”
    Published: [Year not specified]
    Summary: This article examines visual outcomes following surgical intervention for congenital cataracts.

  • “Clinical Characteristics Analysis of 943 Cases of Concomitant Exotropia”
    Published: [Year not specified]
    Summary: This study analyzes the clinical features of a large cohort of patients with concomitant exotropia.

  • “Myf-5 Expression Study in Medial Rectus Muscle of Concomitant Exotropia”
    Published: [Year not specified]
    Summary: This research delves into the expression of Myf-5 in the medial rectus muscle among patients with concomitant exotropia.

  • “Endoscopic Medial Orbital Wall Decompression for Thyroid-Associated Ophthalmopathy”
    Published: [Year not specified]
    Summary: This paper discusses the outcomes of endoscopic medial orbital wall decompression in treating thyroid-associated eye diseases.

  • “A Case of Posterior Lenticonus Combined with Posterior Subcapsular Cataract”
    Published: [Year not specified]
    Summary: This case report details the clinical presentation and management of a patient with posterior lenticonus and posterior subcapsular cataract.

  • “Clinical Efficacy of Corneal Collagen Crosslinking in Treating Juvenile Keratoconus”
    Published: [Year not specified]
    Summary: This study evaluates the effectiveness of corneal collagen crosslinking in managing keratoconus among juvenile patients.